Page last updated: 2024-08-21

thiazoles and Necrotizing Pyelonephritis

thiazoles has been researched along with Necrotizing Pyelonephritis in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (22.22)	29.6817
2010's	3 (33.33)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Bose, SK; Chhibber, S; Harjai, K; Sharma, K	1
Brumbaugh, AR; Mobley, HL; Smith, SN	1
Brumbaugh, AR; Hazen, TH; Himpsl, SD; Mobley, HL; Rasko, DA; Smith, SN; Subashchandrabose, S	1
Aricioglu, A; Bozkirli, I; Cumaoglu, A; Gonul, II; Gurocak, S; Sen, I; Tan, O; Ure, I	1
Gajewski, A; Horcajada, JP; Jimenez de Anta, MT; Johnson, JR; Kuskowski, MA; Soto, S; Vila, J	1
Larcombe, J	1
Bosio, G; Soranzo, ML	1
Posada, HR	1
De Santis, R; Legramante, A; Manno, G; Pagliari, M	1

Reviews

1 review(s) available for thiazoles and Necrotizing Pyelonephritis

Article	Year
Urinary tract infection in children. Clinical evidence, 2005, Issue:13 Topics: Anti-Bacterial Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Pyelonephritis; Pyrrolidonecarboxylic Acid; Secondary Prevention; Thiazoles; Thiazolidines; Urinary Tract Infections; Vesico-Ureteral Reflux	2005

Trials

1 trial(s) available for thiazoles and Necrotizing Pyelonephritis

Article	Year
[Clinical experiments with a new derivative of 6-aminopenicillanic acid: hetacillin potassium]. Minerva medica, 1972, Nov-17, Volume: 63, Issue:82 Topics: Acute Disease; Administration, Oral; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Child; Clinical Trials as Topic; Drug Combinations; Drug Synergism; Drug Tolerance; Evaluation Studies as Topic; Female; Humans; Imidazoles; Infant; Injections, Intramuscular; Lidocaine; Male; Meningitis; Middle Aged; Penicillins; Pyelonephritis; Thiazoles	1972

Article

Year

[Clinical experiments with a new derivative of 6-aminopenicillanic acid: hetacillin potassium].

Minerva medica, 1972, Nov-17, Volume: 63, Issue:82

Topics: Acute Disease; Administration, Oral; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Child; Clinical Trials as Topic; Drug Combinations; Drug Synergism; Drug Tolerance; Evaluation Studies as Topic; Female; Humans; Imidazoles; Infant; Injections, Intramuscular; Lidocaine; Male; Meningitis; Middle Aged; Penicillins; Pyelonephritis; Thiazoles

1972

Other Studies

7 other study(ies) available for thiazoles and Necrotizing Pyelonephritis

Article	Year
Exploring the Therapeutic Efficacy of Zingerone Nanoparticles in Treating Biofilm-Associated Pyelonephritis Caused by Pseudomonas aeruginosa in the Murine Model. Inflammation, 2020, Volume: 43, Issue:6 Topics: Animals; Biofilms; Disease Models, Animal; Guaiacol; HEK293 Cells; Humans; Inflammation; Malondialdehyde; Mice; Microscopy, Electron, Scanning; Nanoparticles; Peroxidase; Phagocytosis; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Stem Cells; Tetrazolium Salts; Thiazoles	2020
Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infection and immunity, 2013, Volume: 81, Issue:9 Topics: Administration, Intranasal; Animals; Antibodies, Bacterial; Antigens, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Immunity, Humoral; Immunization; Immunoglobulin A; Immunoglobulin G; Iron; Mice; Mice, Inbred CBA; Phenols; Pyelonephritis; Receptors, Cell Surface; Siderophores; Thiazoles; Urinary Tract Infections; Uropathogenic Escherichia coli; Vaccination	2013
Blocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection. Infection and immunity, 2015, Volume: 83, Issue:4 Topics: Animals; Antibodies, Monoclonal; Bacterial Vaccines; Cystitis; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Phenols; Pyelonephritis; Receptors, Cell Surface; Thiazoles; Urinary Tract Infections; Uropathogenic Escherichia coli	2015
Renal tissue damage after experimental pyelonephritis: role of antioxidants and selective cyclooxygenase-2 inhibitors. Urology, 2010, Volume: 76, Issue:2 Topics: Animals; Anti-Bacterial Agents; Antioxidants; Carnitine; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Male; Meloxicam; Oxidative Stress; Pyelonephritis; Rats; Rats, Wistar; Thiazines; Thiazoles	2010
Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. The Journal of infectious diseases, 2005, Jan-01, Volume: 191, Issue:1 Topics: Adhesins, Bacterial; Adult; Aged; Bacterial Outer Membrane Proteins; Bacteriocins; Cystitis; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fimbriae Proteins; Fimbriae, Bacterial; Genomic Islands; Humans; Lectins; Male; Membrane Proteins; Middle Aged; Peptide Hydrolases; Phenols; Porins; Prostatitis; Pyelonephritis; Receptors, Cell Surface; Spain; Thiazoles; Urine; Virulence Factors	2005
[Clinical evaluation of a new derivative of 6-amino-penicillanic acid]. Revista brasileira de medicina, 1970, Volume: 27, Issue:5 Topics: Bacteriuria; Escherichia coli; Escherichia coli Infections; Humans; Liver Function Tests; Pyelonephritis; Thiazoles	1970
[A particularly active chemotherapeutic agent in infections of the urinary tracts]. Minerva medica, 1965, Oct-10, Volume: 56, Issue:81 Topics: Cystitis; Female; Furans; Humans; Kidney Calculi; Male; Pyelonephritis; Thiazoles	1965